AbbVie and Frontier Medicines recently announced a multi-year global strategic collaboration to discover, develop, and commercialize a pipeline of innovative novel drug therapies against...
Eli Lilly & Company recently announced that the US government has purchased 650,000 additional doses of its neutralizing COVID-19 antibody, LY-CoV555, for $812.5 million.
The doses will be...
HHS recently announced that it will allocate initial doses of Regeneron’s investigational monoclonal COVID-19 antibody therapy immediately.
Weekly allocations to state and territorial health...
Eli Lilly & Company and Precision BioSciences recently announced a collaboration to research and develop potential in vivo gene therapies for genetic disorders.
The collaboration and exclusive...
Even in a public health crisis, value-based drug pricing warrants consideration, according to arecent Health Affairs analysis reviewing alternative pricing options for COVID-19 treatment.
Daniel...
Amazon is moving into the pharmacy business by launching its own online pharmacy and prescription delivery services, the company recently announced.
The first offering, Amazon Pharmacy, allows...
Although prepublication news releases for COVID-19 antibody drugs are common, they often leave clinicians uncertain about how to best leverage the treatments, which are usually in short supply,...
Boston Children’s Hospital and Deerfield Management Company recently announced a research collaboration aimed at advancing drug discovery and development to address rare and complex pediatric...
FDA recently issued an emergency use authorization for Eli Lilly & Company’s COVID-19 antibody treatment for use in mild to moderate coronavirus in adults and pediatric patients.
The...
Specialty drugs accounted for 37.7 percent of retail and mail order prescription spending net of rebates in 2016-2017, a recent Health Affairs study found.
Researchers leveraged nationally...
Sanofi recently signed a definitive agreement to acquire biopharmaceutical company, Kiadis, in a $359 million pharma acquisition deal.
Under the agreement, Sanofi will offer $6.40 per share to develop...
HHS and the Department of Defense (DoD) recently announced an agreement with Eli Lilly and Company to purchase the first doses of the company’s COVID-19 antibody therapeutic, LY-CoV555.
The...
Roche and Atea Pharmaceuticals recently partnered to develop, manufacture, and distribute Atea’s investigational oral COVID-19 antiviral globally.
The oral treatment, AT-527, is a direct-acting...
HHS and the Department of Defense (DoD) recently announced an agreement with AstraZeneca for late-stage development and large-scale manufacturing of the company’s COVID-19 antibody cocktail,...
Eli Lilly and Company and the Bill & Melinda Gates Foundation recently entered into an agreement to facilitate access to future COVID-19 antibody therapies in low-and middle-income...
Insulin prices are more than eight times higher in the US than in 32 comparable, high-income nations combined, according to a new RAND Corporation study.
In the analysis, researchers used...
AstraZeneca, Gilead, Johnson & Johnson, and other major pharmaceutical companies recently backed efforts to expand global access to COVID-19 vaccines, diagnostics, and therapeutics.
In a joint...
Eli Lilly and Amgen recently announced a global manufacturing collaboration to increase the supply of Lilly’s potential COVID-19 antibody therapies.
If one or more of Lilly’s...
Sanofi and GSK recently finalized an agreement with the European Commission (EC) for the supply of up to 300 million doses of their COVID-19 vaccine, once the vaccine is approved.
The agreement will...
Although prices for migraine medications rose by 40 percent through 2017, they sharply declined at the beginning of 2018 and haven’t seen much of an increase since, according to a GoodRx report....
